You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

127 search results for: symposium

ERS 2023 | Pediatric Asthma <b>Symposium</b>: Patient Case Discussion

expert video

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion

11 min

Pulmonology

Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.

expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

13 min

Dermatology

Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.

expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis - Q&As

11 min

Dermatology

Expert insights on the plasticity of inflammation, atopic dermatitis endotypes, and dysbiosis – Audience Q&A from the ADVENT symposium at ISID 2023.

expert video

Role of Type 2 Inflammation in Chronic Inflammatory Diseases

15 min

Dermatology

Type 2 inflammatory mechanisms and key type 2 cytokines in the pathogenesis of atopic dermatitis – Presentation from the ADVENT symposium at ISID 2023

expert video

Immune System, Microbiome and Neuroimmune Crosstalk in the Skin: Implications for AD

18 min

Dermatology

The role of dysbiosis in the propagation of type 2 inflammation and itch in atopic dermatitis – a presentation from the ADVENT symposium at ISID 2023.

expert video

The Disease Burden of AD in Children and the Impact of Type 2 Comorbidities 

12 min

Dermatology

Multidimensional disease burden of atopic dermatitis in children from a real-world case study – Presentation from the ADVENT symposium at EAACI 2023.

expert video

Fibrosis and Type 2 Inflammation in PN

2 min

Dermatology

The pathophysiology of fibrosis, a key component of skin manifestations in prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023

expert video

AD and PN: Diagnosis and Impact on Quality of Life

1 min

Dermatology

Approaches to diagnosis and the multidimensional burden of atopic dermatitis and prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.

expert video

Cutaneous Manifestations in AD & PN: Role of Type 2 Inflammation

24 min

Dermatology

Type 2 inflammation in the distinct cutaneous manifestations of atopic dermatitis and prurigo nodularis – a clip from the ADVENT symposium at AAD 2023.

expert video

PN and AD: Distinct Diseases with Underlying Type 2 Inflammation

1 min

Dermatology

Prurigo nodularis (PN) and atopic dermatitis (AD): Distinct diseases with underlying type 2 inflammation – highlights from the ADVENT symposium at AAD 2023.

expert video

Neuroimmune Axis and Pruritus in PN

2 min

Dermatology

Changes in nerve density and dysfunction of the neuroimmune axis drive pruritus in prurigo nodularis – Highlight from the ADVENT symposium at AAD 2023.

expert video

Type 2 Inflammation and Chronic Pruritus in AD and PN

7 min

Dermatology

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AustraliaChange country/region